Last-minute settlements delay Ohio opioid trial
Three drug distributors and a pharma company reached deals to avoid going to trial Monday.
Most recent articles by Alison Kanski
Five things for pharma marketers to know: Monday, October 21, 2019
FDA finds asbestos in J&J baby powder; Pelosi’s drug price bill passes first House committee; Sanofi recalls heartburn medicine Zantac over traces of carcinogen.
Five things for pharma marketers to know: Friday, October 18, 2019
Juul suspends sale of fruity flavors; New cases of vaping-related illness slow this week; Pelosi’s drug pricing bill “dead on arrival” in the Senate.
H4B Catapult leader Jill Beene joins McCann Health Echo
Beene joined the agency this week as president.
Healthcare moments from Tuesday’s Democratic debate
Healthcare-related topics included tax increases under Medicare For All and holding pharma accountable for the opioid epidemic.
Five things for pharma marketers to know: Wednesday, October 16, 2019
Drug distributors in talks to settle opioid lawsuits for $18 billion; J&J Q3 earnings beat expectations; Ancestry launches genetic health testing.
Survey: Patients want more from pharma brand websites
Patients are looking for tools like doctor directories and the ability to book appointments on branded pharma websites.
Five things for pharma marketers to know: Tuesday, October 15, 2019
Nearly all patients with vaping illness end up in hospital; Purdue tries to halt opioid lawsuits; House panel requests marketing documents from e-cigarette Vuse.
PSA compares concussions in youth football to smoking
The Concussion Legacy Foundation and Fingerpaint are warning parents about the risks of tackle football before age 14.
Five things for pharma marketers to know: Friday, October 11, 2019
MM&M’s Platinum award goes to teen vaccine advocate Ethan Lindenberger; The Titanium award for best in show went to The Rape Tax campaign; Marketers from Novartis, Amgen and ReachMD won gold.
